We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

VEDA LAB

VEDALAB focuses on the development, production and marketing of in vitro immunodiagnostic reagents and instruments. I... read more Featured Products: More products

Download Mobile App





Vedalab Exhibits Rapid Diagnostic Tests

By LabMedica International staff writers
Posted on 11 Nov 2024

Vedalab (Cerisé, France) is showcasing its wide range of rapid diagnostic tests at the MEDICA exhibition from November 11th to 14th, 2024 being held in Dusseldorf, Germany. More...

Vedalab offers a wide range of immunochromatographic rapid tests which are being highlighted at the trade fair. This includes the new Vitamin D-CHECK-1 immunochromatographic rapid test for the quantitative determination of Vitamin D in plasma or serum samples and the Toxo IgG-CHECK-1 immunochromatographic rapid test for the qualitative detection of IgG antibodies to Toxoplasma gondii in whole blood, plasma or serum samples. Vedalab’s quantitative rapid tests are designed for use on its EASY READER+ instrument showcased at MEDICA 2024. This POC reader enables quantitative measurements from finger-prick whole blood samples using rapid lateral flow tests. The instrument includes the most advanced and up-to-date technologies such as touch screen, enhanced memory, and internet upgrading. The EASY READER+ and quantitative rapid tests are designed for healthcare professionals, for use in physician’s offices, clinical laboratories, and online pharmacies, and for consumers through organizations that provide diagnostic information.

Vedalab’s EASY READER+ and quantitative rapid tests are widely used as screening tools for various medical conditions and diseases. Vedalab is also highlighting its range of immunochromatographic rapid tests for the quantitative detection of AFP (alpha-fetoprotein), beta chain specific hCG (human chorionic gonadotrophin), C-peptide, CA 125 (ovarian cancer antigen), Cancer Antigen 15-3 (CA 15-3), Cancer Antigen 19-9 (CA 19-9), Calprotectin, CEA (carcinoembryonic antigen), Creatine Kinase MB isoenzyme, Cortisol, C-reactive protein, and D-DIMER in whole blood, serum, urine or plasma samples. These tests generate accurate, rapid, and cost-effective diagnostic information for acute and chronic conditions affecting men's and women's health at various stages of life.

Related Links:
Vedalab


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
See-Saw Rocking Shaker
SH-200D-S-L
New
Whole Blood Control
Lyphochek Whole Blood Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Non-coding RNAs CBR3-AS1 and PCA3 can be utilized as therapeutic targets and prognostic biomarkers in gastric cancer (Photo courtesy of Adobe Stock)

Promising Molecular Markers Support Earlier Diagnosis of Gastric Cancer

Late detection continues to make gastric cancer one of the leading causes of cancer-related deaths globally. With improved early detection tools urgently needed, researchers have now identified two long... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: The tip optofluidic immunoassay platform enables rapid, multiplexed antibody profiling using only 1 μL of fingertip blood (Photo courtesy of hLife, DOI:10.1016/j.hlife.2025.04.005)

POC Diagnostic Platform Performs Immune Analysis Using One Drop of Fingertip Blood

As new COVID-19 variants continue to emerge and individuals accumulate complex histories of vaccination and infection, there is an urgent need for diagnostic tools that can quickly and accurately assess... Read more

Pathology

view channel
Image: The new technology combines a rapid hemoglobin test with a smartphone app (Photo courtesy of 123RF)

Smartphone-Based Rapid Hemoglobin Test Accurately Detects Colorectal Cancer

Despite the availability of colorectal cancer screening programs, participation remains low, especially for fecal immunochemical tests (FIT), a non-invasive method to detect hidden blood in the stool.... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.